Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Obesity Intervention Devices Market, by End User
1.4.2 North America Obesity Intervention Devices Market, by Device
1.4.3 North America Obesity Intervention Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Obesity Intervention Devices Market by End User
3.1 North America Hospitals Market by Country
3.2 North America Clinics & Others Market by Country
Chapter 4. North America Obesity Intervention Devices Market by Device
4.1 North America Gastric Bands Market by Country
4.2 North America Gastric Balloon Market by Country
4.3 North America Gastric Stimulation System Market by Country
Chapter 5. North America Obesity Intervention Devices Market by Country
5.1 US Obesity Intervention Devices Market
5.1.1 US Obesity Intervention Devices Market by End User
5.1.2 US Obesity Intervention Devices Market by Device
5.2 Canada Obesity Intervention Devices Market
5.2.1 Canada Obesity Intervention Devices Market by End User
5.2.2 Canada Obesity Intervention Devices Market by Device
5.3 Mexico Obesity Intervention Devices Market
5.3.1 Mexico Obesity Intervention Devices Market by End User
5.3.2 Mexico Obesity Intervention Devices Market by Device
5.4 Rest of North America Obesity Intervention Devices Market
5.4.1 Rest of North America Obesity Intervention Devices Market by End User
5.4.2 Rest of North America Obesity Intervention Devices Market by Device
Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Apollo Endosurgery, Inc. (Boston Scientific Corporation)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals and Trials:
6.3 ReShape Lifesciences, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research and Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 AbbVie, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.5 Allurion Technologies, Inc.
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Approvals and Trials:
6.5.2.2 Product Launches and Product Expansions:
6.6 Spatz FGIA, Inc.
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Approvals and trials:
6.7 Cousin Surgery
6.7.1 Company Overview
6.8 A.M.I. GmbH
6.8.1 Company Overview
6.9 ENDALIS
6.9.1 Company Overview
6.10. GI Dynamics, Inc.
6.10.1 Company Overview
Unique Offerings 